Decided

No. 15-1195

Amgen Inc., et al. v. Sandoz Inc.

from the United States Court of Appeals for the Federal Circuit

See other cases from the Federal Circuit.

Docket Entries

JUDGMENT ISSUED.

Adjudged to be VACATED IN PART, REVERSED IN PART, and case REMANDED. Thomas, J., delivered the opinion for a unanimous Court. Breyer, J., filed a concurring opinion. VIDED.

Argued. For petitioner in No. 15-1039: Deanne E. Maynard, Washington, D. C.; and Anthony A. Yang, Assistant to the Solicitor General, Department of Justice, Washington, D. C. (for United States, as amicus curiae.) For petitioners in 15-1195: Seth P. Waxman, Washington, D. C. VIDED.

Reply of petitioners Amgen Inc., et al. filed. (Distributed)

Motion of the Acting Solicitor General for leave to participate in oral argument as amici curiae and for divided argument GRANTED. VIDED. Justice Gorsuch too no part in the consideration or decision of this motion.

Consolidated Response and Reply Brief of Sandoz Inc. filed. VIDED. (Distributed)

Record received from the U.S.C.A. for the Federal Circuit. The record is available on PACER, except for confidential materials transmitted separately. VIDED.

CIRCULATED.

Brief amicus curiae of Janssen Biotech, Inc. filed. VIDED.

Brief amicus curiae of Biotechnology Innovation Organization. filed. VIDED.

Brief amicus curiae of Genentech, Inc. filed. VIDED.

Brief amicus curiae of AbbVie Inc. filed. VIDED.

Brief amici curiae of Eleven Professors filed.

Motion of the Acting Solicitor General for leave to participate in oral argument as amicus curiae and for divided argument filed. VIDED.

Opening and Response Brief for Amgen Inc., et al. filed. VIDED.

Record requested from the U.S.C.A. for the Federal Circuit. VIDED.

Motion to dispense with printing the joint appendix filed by petitioners GRANTED. VIDED.

Brief amicus curiae of Coherus Biosciences, Inc. filed. VIDED.

SET FOR ARGUMENT ON Wednesday, April 26, 2017. VIDED.

Brief amicus curiae of Mylan Inc. filed. VIDED.

Brief amicus curiae of Biosimilars Council filed. VIDED.

Brief amicus curiae of United States filed. VIDED.

Brief amicus curiae of America's Insurance Health Plans filed. VIDED.

Brief amici curiae of Apotex Inc. and Apotex Corp. filed. VIDED.

Joint motion of the parties to dispense with printing the joint appendix filed. VIDED.

The following briefing schedule is adopted: Petitioner in No. 15-1039 will file an opening brief limited to the question presented in its petition, not to exceed 15,000 words, on or before Friday, February 10, 2017. Petitioners in No. 15-1195 will file a consolidated opening brief on the question presented in their petition and response brief, not to exceed 19,000 words, on or before Friday, March 10, 2017. Petitioner in No. 15-1039 will file a consolidated response brief and reply brief, not to exceed 10,000 words, on or before Friday, March 31, 2017. Petitioners in No. 15-1195 will file a reply brief, not to exceed 6,000 words, on or before Friday, April 14, 2017. Any brief of an amicus curiae in support of petitioner in No. 15-1039 or in support of neither party is to be filed on or before Friday, February 17, 2017, and the brief should bear a light green cover. Any brief of an amicus curiae in support of petitioners in No. 15-1195 is to be filed on or before Friday, March 17, 2017, and the brie...

Petition GRANTED. The petition for a writ of certiorari in No. 15-1039 is granted. The cases are consolidated and a total of one hour is allotted for oral argument.

DISTRIBUTED for Conference of January 13, 2017.

DISTRIBUTED for Conference of January 6, 2017.

Supplemental brief of petitioners Amgen Inc., et al. filed. VIDED.

Brief amicus curiae of United States filed. VIDED.

The Solicitor General is invited to file a brief in this case expressing the views of the United States.

DISTRIBUTED for Conference of June 16, 2016.

Reply of petitioners Amgen Inc., et al. filed.

Brief of respondent Sandoz Inc. in opposition filed.

Order extending time to file response to petition to and including May 17, 2016.

Petition for a writ of certiorari filed. (Response due April 22, 2016)

Parties

Amgen Inc., et al., Petitioner, represented by Seth P. Waxman

Amgen Inc., et al., Petitioner, represented by Nicholas Groombridge

Sandoz Inc., Respondent, represented by Deanne E. Maynard

Amici Curiae

AbbVie Inc.., Amicus Curiae, represented by Melissa Arbus Sherry

America's Insurance Health Plans., Amicus Curiae, represented by Carlos T. Angulo

Apotex Inc. and Apotex Corp., Amicus Curiae, represented by David C. Frederick

Biosimilars Council, Amicus Curiae, represented by William M. Jay

Biotechnology Innovation Organization, Amicus Curiae, represented by Donald R. Ware

Coherus Biosciences, Inc., Amicus Curiae, represented by Craig E. Countryman

Eleven Professors, Amicus Curiae, represented by Kevin E. Noonan

Genentech, Inc., Amicus Curiae, represented by E. Joshua Rosenkranz

Janssen Biotech, Inc., Amicus Curiae, represented by Gregory L. Diskant

Mylan Inc., Amicus Curiae, represented by William A. Rakoczy

United States, Amicus Curiae, represented by Anthony Alan Yang

United States, Amicus Curiae, represented by Jeffrey B. Wall

 
Last updated: August 21, 2017